Very early researchUnknownNCT06360250
What this trial is testing
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of the Fully Human Anti-tetanus Toxin Monoclonal Antibody A82 / B86 Injection Combination Formulation
Who this might be right for
Clostridium Tetanus
Changchun BCHT Biotechnology Co. 190